4
Changes in Ownership
Oncotelic Therapeutics, Inc. Filed Acc 0001493152-26-034397
Options or other derivatives
- CRO/CMO acquired 250 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Fein Seymour Howard CRO/CMO | 2026-07-10 | Grant or award · Restricted stock Units | +250 | 250 | D | ||
Loading xslF345X06/ownership.xml…